LIMN (Liminatus Pharma, Inc. Class A Common Stock) Stock Analysis - Politician Trades

Liminatus Pharma, Inc. Class A Common Stock (LIMN) is a publicly traded Healthcare sector company. As of May 21, 2026, LIMN trades at $0.29 with a market cap of $8.40M and a P/E ratio of -0.43. LIMN moved -1.21% today. Year to date, LIMN is -72.50%; over the trailing twelve months it is -97.02%. Its 52-week range spans $0.16 to $33.66. Rallies surfaces LIMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded LIMN stock?

Rallies tracks politician and congressional stock disclosures for LIMN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

LIMN Key Metrics

Key financial metrics for LIMN
MetricValue
Price$0.29
Market Cap$8.40M
P/E Ratio-0.43
EPS$-0.43
Dividend Yield0.00%
52-Week High$33.66
52-Week Low$0.16
Volume83.47M
Avg Volume0
Revenue (TTM)$0
Net Income$-10.21M
Gross Margin0.00%

Latest LIMN News

LIMN Analyst Consensus

LIMN analyst coverage data. Average price target: $0.00.

Common questions about LIMN

Which politicians traded LIMN stock?
Rallies tracks politician and congressional stock disclosures for LIMN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in LIMN?
Yes. Rallies tracks politician and congressional stock disclosures for LIMN, including reported purchases, sales, dates, owners, and trade amounts when available.
Is LIMN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LIMN. It does not provide personalized investment advice.
LIMN

LIMN